
Organic Process Research and Development p. 331 - 342 (2012)
Update date:2022-08-11
Topics:
Kaemmerer, Henning
Horvath, Zoltan
Lee, Ju Weon
Kaspereit, Malte
Arnell, Robert
Hedberg, Martin
Herschend, Bjoern
Jones, Matthew J.
Larson, Kerstin
Lorenz, Heike
Seidel-Morgensten, Andreas
A racemic mixture of bicalutamide, a drug substance used in the treatment of prostate cancer, was separated by simulated moving bed chromatography, with the objective of maximizing throughput at reduced outlet purity. The enriched extract stream was purified further by a crystallization process exploiting a shift in the eutectic composition. The optimal purity in between both process steps was identified. The separation scheme developed was validated on a scale of 600 g, and the results were compared to those of state-of-the art and discussed. The investigated scheme revealed a wide range of promising coupling conditions while showing superior productivities and enhanced process robustness.
View More
HANGZHOU ZHONGCHANG SCIENTIFIC CO.,LTD
Contact:+86-571-88932183
Address:Hangzhou
Wuxi Pharma-Trading Import & Export Co.,Ltd.
Contact:+86-510-82304590 82716390
Address:Room 523,Youzu Alliance Building,No.88 Renmin Zhonglu,Wuxi,Jiangsu,China
Xinchang Yueding Chemical Co., Ltd.
Contact:86-571-56926323
Address:NO.90 BEIMENCHENGWAI CHENGGUAN TOWN XINCHANG
Luojiang Chenming Biological Products Co
Contact:+86 15000297032
Address:GROUP NO.4, HE SHENG VILLAGE, PANLONG TOWN,
Contact:86-21 60347964
Address:No.1304, West Meilong Road, Minhang District, Shanghai, China
Doi:10.1002/anie.200500669
(2006)Doi:10.3390/molecules201219881
(2015)Doi:10.1246/cl.1992.795
(1992)Doi:10.1021/acs.orglett.8b01857
(2018)Doi:10.1055/s-1980-29276
(1980)Doi:10.1002/bio.3728
(2020)